Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.

Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M.

Eur J Haematol. 2013 Mar;90(3):202-9. doi: 10.1111/ejh.12061. Epub 2013 Jan 20.

PMID:
23278124
[PubMed - indexed for MEDLINE]
2.

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period.

Mariño Z, Crespo G, D'Amato M, Brambilla N, Giacovelli G, Rovati L, Costa J, Navasa M, Forns X.

J Hepatol. 2013 Mar;58(3):415-20. doi: 10.1016/j.jhep.2012.09.034. Epub 2012 Oct 11.

PMID:
23063567
[PubMed - indexed for MEDLINE]
3.

The treatment of melasma by silymarin cream.

Altaei T.

BMC Dermatol. 2012 Oct 2;12:18. doi: 10.1186/1471-5945-12-18.

PMID:
23031632
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR; Silymarin in NASH and C Hepatitis (SyNCH) Study Group.

JAMA. 2012 Jul 18;308(3):274-82. doi: 10.1001/jama.2012.8265.

PMID:
22797645
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.

Fallahzadeh MK, Dormanesh B, Sagheb MM, Roozbeh J, Vessal G, Pakfetrat M, Daneshbod Y, Kamali-Sarvestani E, Lankarani KB.

Am J Kidney Dis. 2012 Dec;60(6):896-903. doi: 10.1053/j.ajkd.2012.06.005. Epub 2012 Jul 7.

PMID:
22770926
[PubMed - indexed for MEDLINE]
6.

Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial.

Yakoot M, Salem A.

BMC Gastroenterol. 2012 Apr 12;12:32. doi: 10.1186/1471-230X-12-32.

PMID:
22497849
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.

Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, Cursaro C, Danila M, de Sio I, Floreani A, Freni MA, Grieco A, Groppo M, Lazzari R, Lobello S, Lorefice E, Margotti M, Miele L, Milani S, Okolicsanyi L, Palasciano G, Portincasa P, Saltarelli P, Smedile A, Somalvico F, Spadaro A, Sporea I, Sorrentino P, Vecchione R, Tuccillo C, Del Vecchio Blanco C, Federico A.

Free Radic Biol Med. 2012 May 1;52(9):1658-65. doi: 10.1016/j.freeradbiomed.2012.02.008. Epub 2012 Feb 15.

PMID:
22343419
[PubMed - indexed for MEDLINE]
8.

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C.

Reddy KR, Belle SH, Fried MW, Afdhal N, Navarro VJ, Hawke RL, Wahed AS, Doo E, Meyers CM; SyNCH Study Group.

Clin Trials. 2012 Feb;9(1):102-12. doi: 10.1177/1740774511427064. Epub 2011 Nov 4.

PMID:
22058086
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effect of silymarin in the treatment of allergic rhinitis.

Bakhshaee M, Jabbari F, Hoseini S, Farid R, Sadeghian MH, Rajati M, Mohamadpoor AH, Movahhed R, Zamani MA.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):904-9. doi: 10.1177/0194599811423504. Epub 2011 Sep 27.

PMID:
21952357
[PubMed - indexed for MEDLINE]
10.

Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

Schrieber SJ, Hawke RL, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Meyers CM, Doo E, Fried MW.

Drug Metab Dispos. 2011 Dec;39(12):2182-90. doi: 10.1124/dmd.111.040212. Epub 2011 Aug 24.

PMID:
21865319
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.

Roozbeh J, Shahriyari B, Akmali M, Vessal G, Pakfetrat M, Raees Jalali GA, Afshariani R, Hasheminasab M, Ghahramani N.

Ren Fail. 2011;33(2):118-23. doi: 10.3109/0886022X.2010.541579.

PMID:
21332331
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial.

Vidlar A, Vostalova J, Ulrichova J, Student V, Krajicek M, Vrbkova J, Simanek V.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Sep;154(3):239-44.

PMID:
21048810
[PubMed - indexed for MEDLINE]
Free Article
13.

Evaluation of effect of silymarin on granulosa cell apoptosis and follicular development in patients undergoing in vitro fertilization.

Moosavifar N, Mohammadpour AH, Jallali M, Karimiz G, Saberi H.

East Mediterr Health J. 2010 Jun;16(6):642-5. Erratum in: East Mediterr Health J. 2010 Aug;16(8):892.

PMID:
20799592
[PubMed - indexed for MEDLINE]
14.

The iron-chelating potential of silybin in patients with hereditary haemochromatosis.

Hutchinson C, Bomford A, Geissler CA.

Eur J Clin Nutr. 2010 Oct;64(10):1239-41. doi: 10.1038/ejcn.2010.136. Epub 2010 Jul 14.

PMID:
20628405
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C.

Hawke RL, Schrieber SJ, Soule TA, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Berman J, Liu QY, Doo E, Fried MW; SyNCH Trial Group.

J Clin Pharmacol. 2010 Apr;50(4):434-49. doi: 10.1177/0091270009347475. Epub 2009 Oct 19.

PMID:
19841158
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.

Han Y, Guo D, Chen Y, Tan ZR, Zhou HH.

Xenobiotica. 2009 Sep;39(9):694-9. doi: 10.1080/00498250903060077.

PMID:
19555315
[PubMed - indexed for MEDLINE]
17.

Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.

Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.

Fundam Clin Pharmacol. 2009 Jun;23(3):359-65. doi: 10.1111/j.1472-8206.2009.00681.x. Epub 2009 May 7.

PMID:
19453758
[PubMed - indexed for MEDLINE]
18.

A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.

El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A, El-Kassas M, Esmat G, Strickland GT.

Phytomedicine. 2009 May;16(5):391-400. doi: 10.1016/j.phymed.2009.02.002. Epub 2009 Mar 19.

PMID:
19303273
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers.

Han Y, Guo D, Chen Y, Chen Y, Tan ZR, Zhou HH.

Eur J Clin Pharmacol. 2009 Jun;65(6):585-91. doi: 10.1007/s00228-009-0624-9. Epub 2009 Feb 17.

PMID:
19221727
[PubMed - indexed for MEDLINE]
20.

Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam.

Hussain SA, Jassim NA, Numan IT, Al-Khalifa II, Abdullah TA.

Saudi Med J. 2009 Jan;30(1):98-103.

PMID:
19139781
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk